CA2172490A1 - Facteurs de reconnaissance d'un recepteur; sequences proteiniques et methodes d'utilisation - Google Patents
Facteurs de reconnaissance d'un recepteur; sequences proteiniques et methodes d'utilisationInfo
- Publication number
- CA2172490A1 CA2172490A1 CA002172490A CA2172490A CA2172490A1 CA 2172490 A1 CA2172490 A1 CA 2172490A1 CA 002172490 A CA002172490 A CA 002172490A CA 2172490 A CA2172490 A CA 2172490A CA 2172490 A1 CA2172490 A1 CA 2172490A1
- Authority
- CA
- Canada
- Prior art keywords
- leu
- glu
- gln
- ser
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Il existe des facteurs de reconnaissance de récepteurs qui reconnaissent le récepteur cellulaire spécifique auquel un ligand spécifique a été fixé, et qui peuvent par conséquent signaler et/ou amorcer la fixation du facteur de transcription au site d'ADN. Le facteur de reconnaissance de récepteurs est dans un cas, une partie d'un facteur de transcription, et peut également avoir une interaction avec d'autres facteurs de transcription afin de provoquer leur activation et leur déplacement jusqu'au noyau pour fixer l'ADN. Le facteur de reconnaissance de récepteurs semble avoir une activité indépendante du second messager, puisque des perturbations manifestes dans des concentrations de second messager n'ont aucun effet. Le concept de l'invention est illustré par les résultats d'études menées avec une transcription de gènes stimulés par interféron (IFN), et notamment, l'activation provoquée par les interférons à la fois IFN alpha et IFN gamma . L'invention concerne également de l'ADN ainsi que des séquences d'acides aminés spécifiques à divers facteurs de reconnaissance des récepteurs humains et murins, ainsi que des fragments polypeptidiques de deux des gènes ISGF-3, des anticorps ayant également été préparés et testés. Les polypeptides confirment une implication directe de la tyrosine kinase dans la transmission du message intracellulaire. De plus l'invention concerne de nombreuses matières et applications diagnostiques et thérapeutiques.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12658893A | 1993-09-24 | 1993-09-24 | |
US12659593A | 1993-09-24 | 1993-09-24 | |
US08/126,588 | 1993-09-24 | ||
US08/126,595 | 1993-09-24 | ||
US21218494A | 1994-03-11 | 1994-03-11 | |
US08/212,185 | 1994-03-11 | ||
US08/212,184 | 1994-03-11 | ||
US08/212,185 US6605442B1 (en) | 1992-03-19 | 1994-03-11 | Methods of testing drugs or agents that modulate the activity of receptor recognition factors |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2172490A1 true CA2172490A1 (fr) | 1995-03-30 |
Family
ID=27494654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002172490A Abandoned CA2172490A1 (fr) | 1993-09-24 | 1994-09-26 | Facteurs de reconnaissance d'un recepteur; sequences proteiniques et methodes d'utilisation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0720652A1 (fr) |
JP (1) | JPH09506243A (fr) |
AU (1) | AU8072194A (fr) |
CA (1) | CA2172490A1 (fr) |
WO (1) | WO1995008629A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0676469A3 (fr) * | 1994-04-04 | 1998-03-25 | Tadamitsu Kishimoto | Facteur de transcription APRF |
US5639858A (en) * | 1995-03-22 | 1997-06-17 | Tularik, Inc. | Human signal transducer and binding assays |
US6030780A (en) * | 1996-10-15 | 2000-02-29 | The Rockefeller University | Purified Stat proteins and methods of purifying thereof |
US6720154B1 (en) | 1997-10-15 | 2004-04-13 | The Rockefeller University | Purified stat proteins and methods of purifying thereof |
EP0905234A3 (fr) | 1997-09-16 | 1999-06-23 | Applied Research Systems Ars Holding N.V. | Allèles de la protéine STAT3 humaine |
EP0906953A1 (fr) * | 1997-09-16 | 1999-04-07 | Applied Research Systems Ars Holding N.V. | Allèles de la protéine STAT3 humaine |
US6087478A (en) * | 1998-01-23 | 2000-07-11 | The Rockefeller University | Crystal of the N-terminal domain of a STAT protein and methods of use thereof |
US6391572B1 (en) | 1999-08-31 | 2002-05-21 | The Rockefeller University | Methods for identifying modulators of transcriptional activator protein interactions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992008740A2 (fr) * | 1990-11-14 | 1992-05-29 | The Rockefeller University | Facteur de reconnaissance de recepteurs et procedes d'utilisation d'un tel facteur |
EP0637333A1 (fr) * | 1992-03-19 | 1995-02-08 | The Rockefeller University | Facteurs de reconnaissance de recepteurs d'interferon, sequences de proteines et leurs procedes d'utilisation |
-
1994
- 1994-09-26 AU AU80721/94A patent/AU8072194A/en not_active Abandoned
- 1994-09-26 EP EP94931767A patent/EP0720652A1/fr not_active Withdrawn
- 1994-09-26 WO PCT/US1994/010849 patent/WO1995008629A1/fr not_active Application Discontinuation
- 1994-09-26 JP JP7509423A patent/JPH09506243A/ja not_active Ceased
- 1994-09-26 CA CA002172490A patent/CA2172490A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0720652A1 (fr) | 1996-07-10 |
JPH09506243A (ja) | 1997-06-24 |
AU8072194A (en) | 1995-04-10 |
WO1995008629A1 (fr) | 1995-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU743490B2 (en) | NTN-2 member of TNF ligand family | |
JP3966387B2 (ja) | Tnf/ngfスーパーファミリー受容体および可溶性オリゴマー tnf/ngfスーパーファミリー受容体のモジュレーター | |
US5883228A (en) | Functionally active regions of signal transducer and activator of transcription | |
Suhara et al. | Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300 | |
AU7608898A (en) | Ntn-2 member of tnf ligand family | |
US6265160B1 (en) | Method of identifying inhibitors of the Jak-Stat signal transduction pathway | |
US6579697B1 (en) | Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors | |
US5731155A (en) | Compositions for inhibition of intracellular transcription factors and methods therefor | |
US6338949B1 (en) | Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof | |
JPH10510422A (ja) | チロシンリン酸化タンパク質に結合する新規なタンパク質ドメイン | |
US8029778B2 (en) | Methods of using TICAM-1, an adapter protein that binds toll-like receptor 3 | |
US6280955B1 (en) | Interleukin-1 receptor accessory proteins, nucleic acids and methods | |
CA2172490A1 (fr) | Facteurs de reconnaissance d'un recepteur; sequences proteiniques et methodes d'utilisation | |
US5618693A (en) | Interleukin-2 signal transducers and binding assays | |
CA2132317A1 (fr) | Facteurs de reconnaissance des recepteurs de l'ifn, sequences proteiques et methodes d'application | |
US7339039B2 (en) | Nucleic acids encoding receptor recognition factors, and methods of use thereof | |
JP2000125888A (ja) | シアロアドヘシンファミリ―メンバ――3 | |
KR20020069140A (ko) | 종양 괴사 인자 수용체 관련 인자 6 억제 단백질 | |
GB2346882A (en) | Human vanilloid receptor-like receptor | |
US20050084916A1 (en) | Identification of the IkappaBNS protein and its products | |
JPH06100595A (ja) | Il−8受容体 | |
IL103051A (en) | Molecules binding to the p75 tnf receptor, their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |